Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Simulating the impact of non-pharmaceutical interventions limiting transmission in COVID-19 epidemics using a membrane computing model.

microLife·2021
Same author

Obesity status and obesity-associated gut dysbiosis effects on hypothalamic structural covariance.

International journal of obesity (2005)·2021
Same author

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function.

Journal of internal medicine·2021
Same author

Dysbiotic gut microbiota in patients with inflammatory rosacea: another clue towards the existence of a brain-gut-skin axis.

The British journal of dermatology·2021
Same author

Evidence for Succession and Putative Metabolic Roles of Fungi and Bacteria in the Farming Mutualism of the Ambrosia Beetle Xyleborus affinis.

mSystems·2020
Same author

AmAMP1 from Acropora millepora and damicornin define a family of coral-specific antimicrobial peptides related to the Shk toxins of sea anemones.

Developmental and comparative immunology·2020

相关实验视频

Updated: Jul 18, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

在神经介导的倾斜阳性心脏抑制性的治疗中双室节奏:起器与没有治疗:一个多中心随机研究. 血管综合国际研究 (VASIS) 调查人员的调查人员

R Sutton1, M Brignole, C Menozzi

  • 1Departments of Cardiology of Royal Brompton Hospital, London, UK.

Circulation
|July 19, 2000
PubMed
概括

植入具有速率歇斯底里的DDI心脏起器显著降低了严重心脏抑制性的患者中的复发. 这种益处持续了很长一段时间,证明了神经介导昏迷的有效治疗.

更多相关视频

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
04:04

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

相关实验视频

Last Updated: Jul 18, 2026

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
04:04

Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness

Published on: July 11, 2025

科学领域:

  • 心脏病学 心脏病学
  • 神经介导的昏迷是神经介导的
  • 电子生理学 电子生理学

背景情况:

  • 严重的心脏抑制性昏迷在患者管理中构成了重大挑战.
  • 神经介导性昏迷 (NMS) 通常涉及心脏抑制反应,导致反复出现的昏迷发作.
  • 倾斜测试对于诊断NMS和识别特定反应类型至关重要.

研究的目的:

  • 为了比较DDI心脏起器植入与速率歇斯底里斯的疗效,与没有植入在预防同复发的疗效.
  • 评估在患有严重心脏抑制性,倾斜阳性NMS的患者中DDI节拍的长期有效性.
  • 评估倾斜测试在评估治疗疗效方面的作用.

主要方法:

  • 随机对照试验涉及18个欧洲中心42名患者.
  • 随机分配给DDI心脏起器植入 (编程为80bpm与45bpm歇斯底里) 或没有心脏起器的患者.
  • 纳入标准: >=2年3次同步,心脏抑制性 (VSIS类型2A/2B) 倾斜测试的积极反应.

主要成果:

  • 与没有心脏起器组 (61%) (P=0.0006) 相比,心脏起器组 (5%) 的综合征复发率显著降低 (P=0.0006).
  • 平均随访时间为3.7年,表明DDI节奏的长期持续益处.
  • 在注册后的组之间,反复倾斜测试反应没有显著差异,这表明对治疗评估的有用性有限.

结论:

  • 与速率歇斯底里结合的DDI步调是一种有效的治疗方法,可减少严重心脏抑制性NMS的选择性患者的昏迷复发.
  • 在长时间的随访期间,DDI刺激的治疗益处保持不变.
  • 倾斜测试的结果不是可靠的指标来评估节拍疗法的有效性在这个患者队列.